Zobrazeno 1 - 10
of 315
pro vyhledávání: '"HBs antigen"'
Autor:
Rayhaneh Mirzaee, Fahimeh Nemati Mansoor, Mina Mirzaee, Bahareh Golkaran, Akbar Khorasani, Niloufar Rashedi, Fatemeh Asgarhalvaei, Mohammad Ali Savoji, Mehdi Mahdavi
Publikováno v:
Iranian Journal of Basic Medical Sciences, Vol 25, Iss 11, Pp 1326-1333 (2022)
Objective(s): HBsAg vaccine is unable to induce Th1 immune responses. Here, immune responses and long-lived IgG responses of HBsAg-Alum, HBsAg-MF59, as well as HBsAg-MF59 were compared when formulated with PPD. Materials and Methods: BALB/c mice were
Externí odkaz:
https://doaj.org/article/c926d9b4d3324b83991c7c08cbd26d3d
Autor:
Hamzeh Sarvnaz, Sahar Asadi-Asadabad, Mohammad Mehdi Amiri, Mojgan Ghaedi, Ulrike Protzer, Mahmood Jeddi-Tehrani, Forough Golsaz-Shirazi, Fazel Shokri
Publikováno v:
Iranian Journal of Immunology, Vol 19, Iss 3, Pp 278-298 (2022)
Background: Human polyclonal plasma-derived hepatitis B immunoglobulin (HBIG) is currently used for immunoprophylaxis of HBV infection. The development of virus-neutralizing monoclonal antibodies (MAbs) requires the use of optimized cell culture syst
Externí odkaz:
https://doaj.org/article/08d93e9703864110b74a25e3b1bce8f9
Publikováno v:
Modern Medicine, Vol 27, Iss 1, Pp 11-18 (2020)
Chronic hepatitis B still represents a major challenge for clinicians and the public health service even years after the development of an efficient vaccine and potent antiviral agents. The major actual problems in treating chronic hepatitis B (HBV)
Externí odkaz:
https://doaj.org/article/968e76228a644f009650758af48f8894
Autor:
Wemboo Afiwa Halatoko, Akouda Patassi, Pauline Yanogo, Leou Ismael Banla, Adjaho Koba, Zoulkaneiri Issa, Koffi Akolly, Agballa Mébiny-Esso Tchalla, Hamadi Assane, Aboukerim Naba-Mouchedou, Bernard Sawadogo, Simon Nouvura Antara, Kossi Badziklou, Abiba Kere Banla, Didier Koumavi Ekouevi, Idrissa Sanou
Publikováno v:
BMC Public Health, Vol 19, Iss 1, Pp 1-7 (2019)
Abstract Background In Togo, the prevalence of Hepatitis B Virus Surface Antigen (HBsAg) among young people aged 15–24 years was estimated at 16.4% in 2010; however, risk factors for HBsAg carriage are poorly documented. We sought to identify risk
Externí odkaz:
https://doaj.org/article/29919ce2170249449b57f32e48f722ab
Publikováno v:
European Journal of Epidemiology, 2003 Jan 01. 18(10), 1007-1011.
Externí odkaz:
https://www.jstor.org/stable/3582948
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Saber, Mona Ali, Sarhan, Hatem Abdul-Monsef, Fouad, Yasser Mahrous, Elsayed, Mahmoud MA, Hassnine, Alshymaa Ahmed
Publikováno v:
Egyptian Journal of Hospital Medicine; Vol. 86 No. 1 (2022); 696-699
Background: Hepatitis B virus (HBV) infection is increasing globally, posing a serious public health problem. Hepatitis B virus (HBV) infection and mortality are among the leading causes of death worldwide. Concerns for public health are amplified by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24c5dc0f60019e60d35c0fbc4900d051
https://doi.org/10.21608/ejhm.2022.215573
https://doi.org/10.21608/ejhm.2022.215573
Publikováno v:
Romanian Journal of Laboratory Medicine, Vol 29, Iss 1, Pp 105-113 (2021)
Reactivation of hepatitis B virus (HBV) infection has been described in patients with HBsAg negative and antiHBc positive (occult hepatitis B infection -OBI) receiving immunosuppressive therapy (IST). The lack of proper monitoring of patients with th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66d36ae32d94ce30d9d3449d449bb46e
https://doi.org/10.2478/rrlm-2020-0039
https://doi.org/10.2478/rrlm-2020-0039
Autor:
Masayuki Tatemichi, Satsue Nagahama, Masaaki Korenaga, Hitoshi Endo, Hiroyuki Furuya, Yukari Shida, Norihide Takaya, Takaaki Kinoue, Kota Fukai, Satoshi Owada
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
Scientific Reports
Scientific Reports
In Japan, there is no publicly funded screening for hepatitis B virus (HBV) and hepatitis C virus (HCV) infections (using HBs antigen and HCV antibody, respectively) among workers, and workplace health programmes play a crucial role in reducing viral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e21c9d9212481b2d43378743d622a49
http://link.springer.com/article/10.1038/s41598-020-68021-2
http://link.springer.com/article/10.1038/s41598-020-68021-2
Publikováno v:
IP International Journal of Medical Microbiology and Tropical Diseases. 6:62-65
To evaluate the anti-HBs titres among medical students and Health Care Workers (HCW) who are vaccinated against Hepatitis B virus and find the level of protection among HCWs.The study was done at the Department of Microbiology, Nizam’s Institute of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d7a68e6e5928108167270df861e85ee
https://doi.org/10.18231/j.ijmmtd.2020.013
https://doi.org/10.18231/j.ijmmtd.2020.013